NJ ACTS in the News
Funding will advance discovery of novel anti-infectives addressing antimicrobial resistance.
ArrePath, a drug discovery spinout founded by Zemer Gitai, the Edwin Grant Conklin Professor of Biology…
NJ ACTS is pleased to announce the NIH-funded clinical and translational science fellowship opportunity for graduate students and postdoctoral trainees. Required Letters of Intent are due March 31, 2022 by 5 pm. Applications are due April 22, 2022 by 5 pm.
A Princeton-led technology to improve the storage and transport of vaccines and life-saving drugs at room temperature has been selected as one of three university innovations to receive funding for further development from the Philadelphia-based University City Science Center. The technology was developed by Princeton Research Scholar